BC is a highly heterogeneous disease and could be divided into four subtypes, namely, luminal A, luminal B, Her-2 overexpression, and triple negative, which account for 50%, 14.1%, 12.7%, and 23.2% of all BC cases, respectively [2]. Here, ERBB2 is linked to breast cancer.